• 산업공학
• /
• 제10권1호
• /
• pp.119-134
• /
• 1997

The management of blood inventory is very important within the medical care system. The efficient management of blood supplies and demands for transfusions is of great economic and social importance to both hospitals and patients. For any blood type, there is a complex interaction among the optimal inventory level, daily demand level, daily supply level, transfusion to crossmatch ratio, crossmatch release period, issuing policy and the age of arriving units that determine the shortage and outdate rate. In this paper, we develop an efficient decision rule for blood inventory management in a hospital blood bank which can support efficient hospital blood inventory management using simulation. The primary use of the efficient decision rule will be to establish minimum cost function which consists of inventory levels, period in inventory, outdate and shortage rate for whole blood and various component inventories for a hospital blood bank or a transfusion service. If the administrator compute the mean daily demand for each blood type, the mean daily supply for each blood type, the length of the crossmatch release period and the average transfusion to crossmatch ratio, then it is possible to apply the efficient decision rule to compute the optimal inventory level, inventory period, outdate and shortage rate. This rule can also be used as a decision support system that allows the blood bank administrator to do sensitivity analysis related to controllable blood inventory parameters.

• 한국시뮬레이션학회논문지
• /
• 제5권1호
• /
• pp.13-27
• /
• 1996

The management of blood inventory is very important within the medical care system. The efficient management of blood supplies and demands for transfusion is of great economic and social importance to both hospitals and patients. Fro any blood type, there is a complex interaction among the optimal inventory level, daily demand level , daily supply level, transfusion to crossmatch ratio, crossmatch release period, issuing policy and the age of arriving units that determine the shortage and outdate rate. In this paper, we develop an efficient decision rule for blood inventory management in a hospital blood bank which can support efficient hospital blood inventory management using simulation, The primary use of the efficient decision rule will be to establish minimum cost function which consists of inventory levels , period in inventory, outdate and shortage rate for whole blood and various component inventories for a hospital blood bank or a transfusion service, If the adminstrator compute the mean daily demand for each blood type, the mean daily supply for each blood type, the length of the crossmatch release period and the average transfusion to crossmatch ratio , then it is possible to apply the efficient decision rule to compute the optimal inventory level, inventory period , outdate and shortage rate. This rule can also be used as a decision support system that allows the blood bank adminstrator to do sensitivity analysis related to controlled blood inventory parameters.

• Journal of Preventive Medicine and Public Health
• /
• 제21권1호
• /
• pp.195-206
• /
• 1988

Two major issues of the blood bank management are quality assurance and inventory control. Recently, in Korea blood donation has gained popularity increasingly to allow considerable improvement of the quality assurance with respect to blood collection, transportation, storage, component preparation skills and hematological tests. Nevertheless the inventory control, the other issue of blood bank management, has been neglected so far. For the supply of blood by donation barely meets the demand, the blood bank policy on the inventory control has been 'the more the better.' The shortage itself by no means unnecessitate inventory control. In fact, in spite of shortage, no small amount of blood is outdated. The efficient blood inventory control makes it possible to economize the blood usage in the practice of state-of-the-art medical care. For the efficient blood inventory control in Korean hospitals, this tudy is to develop formulae forecasting the standard blood inventory level and suggest a set of policies improving the blood inventory control. For this study informations of $A^+$ whole bloods and packed cells inventory control were collected from a University Hospital and the Central Blood Bank of the Korean Red Cross. Using this informations, 1,461 daily blood inventory records were formulated.48 varieties of blood inventory control environment were identified on the basis of selected combinations of 4 inventory control variables-crossmatch, transfusion, inhospital donation and age of bloods from external supply. In order to decide the optimal blood inventory level for each environment, simulation models were designed to calculate the measures of performance of each environment. After the decision of 48 optimal blood inventory levels, stepwise multiple regression analysis was started where the independent variables were 4 inventory control variables and the dependent variable was optimal inventory level of each environment. Finally the standard blood inventory level decision rule was developed using the backward elimination procedure to select the best regression equation. And the effective alternatives of the issuing policy and crossmatch release period were suggested according to the measures of performance under the condition of the standard blood inventory level. The results of this study' were as follows ; 1. The formulae to calculate the standard blood inventory level($S^*$)was $S^*=2.8617X(d)^{0.9342}$ where d is the mean daily crossmatch(demand) for a blood type. 2. The measures of performace - outdate rate, average period of storage, mean age of transfused bloods, and mean daily available inventory level - were improved after maintenance of the standard inventory level in comparison with the present system. 3. Issuing policy of First In-First Out(FIFO) decreased the outdate rate, while Last In-First Out(LIFO) decreased the mean age of transfused bloods. The decrease of the crossmatch release period reduced the outdate rate and the mean age of transfused bloods.

• 한국국방경영분석학회지
• /
• 제8권2호
• /
• pp.37-55
• /
• 1982

The whole blood inventory control model is developed, shown to provide an accurate representation of actual blood bank operations in Korea. The main difference of the blood bank situations between Korea and the United States is that about 50 percent of all bloods demanded, crossmatched, and held for a particular patient are eventually found not to be required for that patient in case of U.S. while in Korea the crossmatch test is not so significant and almost successful. Accordingly, the model in this paper is focused in seeking the minimum inventory level where neither shortage nor outdating bloods begin to occur, while the Jennings' model, developed in 1970 at MIT OR Center, is the inventory level somewhere between the inventory level 'band' where both shortage and outdating occur.

• 천문학논총
• /
• 제32권1호
• /
• pp.299-303
• /
• 2017

We crossmatch AKARI all-sky survey with the Sloan Digital Sky Survey Data Release 10 (SDSS DR10) and the Final Data Release of the Two-Degree Field Galaxy Redshift Survey (2dFGRS) and identify 118 Ultraluminous Infrared Galaxies (ULIRGs) and one Hyperluminous Infrared Galaxy (HLIRG). We find 40 new ULIRGs and one new HLIRG. ULIRGs in our sample are interacting galaxies or ongoing/post mergers. This is consistent with the fact that ULIRGs are major mergers of disk galaxies. We find that compared to local star forming SDSS galaxies of similar mass, local ULIRGs have lower oxygen abundances and this is consistent with the previous studies.

• 한국임상수의학회지
• /
• 제22권4호
• /
• pp.322-327
• /
• 2005

보체의존성 세포독성반응(CDC)을 이용한 DLA class I교차 반응의 실험방법을 정립함으로써 개의 동종 신장이식 후 초기에 발생되는 초급성 거부반응을 억제하는데 응용하고자 븐 실험을 실시하였다. 체중(약 5kg)과 연령(약 1년령)이 유사한 잡종견을 대상으로 적혈구 교차 반응을 실시하여 상호 음성인 7마리를 실험에 사용하였다. 혈액형이 동일한 개체를 대상으로 CDC검사를 실시하였으며, Anti-dog serum, Hank's balanced salt solution (HBSS), 그리고 자가 혈청을 각각 양성 음성 그리고 자가 대조 혈청으로 이용하였다. Class I보체와 반응시킨 후 에오신으로 염색하여 고정한 다음 위상차 현미경 100배율에서 조사하였다. 국제 Cytotoxicity scoring system에 의하려 죽은 세포가 $20\%$ 이상이면 양성으로 평가하였다. CDC 결과 동일 혈액형 군에서 상호 음성이 나온 경우를 대상으로 상호 동종이식을 실시하여 초급성 거부반응의 발생 정도를 평가하였다. 혈액형이 1.2 B인 4두 중 1두는 자가항체를 가지고 있었다. CDC 결과 동일 혈액형 군에서 각각 1쌍이 상호 음성을 나타내었고, 혈액형이 다른 1쌍에서도 상호 음성이 관찰되었다. 혈액형이 동일하고 CDC음성인 2쌍 4두를 대상으로 상호 신장 이식을 한 결과 4마리 모두 초급성 거부반응이 나타나지 않았다. 이 실험에서 확립한 DLA교차 방법은 동종 이식에서 초급성 거부반응을 억제하는데 효과적인 방법이며, 향후 개의 동종 장기 이식에서 조직적합성 평가를 위해 응용될 수 있을 것이라 사료된다.

• Childhood Kidney Diseases
• /
• 제12권2호
• /
• pp.133-142
• /
• 2008

이식을 위해서는 수여자와 공여자의 혈액형과 HLA type을 알아야 한다. 통상 ABO 혈액형이 적합한 경우 이식할 수 있으며 HLA 부적합은 근래 큰 문제가 되지 않으나 HLA 부적합이 없는 경우 이식장기의 장기생존률이 높다. PRA(panel reactive antibody)는 수여자가 HLA에 감작되었는지 검사하는 방법이며 이식 전에는 반드시 교차반응 검사를 하여 음성인 경우에만 이식을 진행한다. 이식 전후에 donor specific antibody(DSA)를 검사하여 이식장기에 대한 수여자의 면역반응을 예측 할 수 있다. 근래에는 스테로이드, calcineurin inhibitor(cyclosporine, tacrolimus), azathioprine 또는 mycophenolate mofetil (MMF)의 삼제요법을 주로 사용하며 항림프구 항체 (Thymoglobulin 또는 항IL-2 receptor 항체 basiliximab/daclizumab)을 이용하여 이식 초기에 면역억제상태를 induction하는 경우도 많다.

• Laboratory Medicine Online
• /
• 제1권1호
• /
• pp.64-66
• /
• 2011

항-Sd^a는 용혈성 수혈 부작용 발생이 적은 항체이므로, 항체 선별검사에서 의심이 되어도, 항체 동정이 보통은 생략된다. 저자들은 73세 남자 환자에서 수혈 전 비예기 항체 검사에서 혼합시야 반응을 보이면서 항체 동정검사에서 확인되지 않는 항체를 확인하였다. 항-Sd^a 의심하에 추가적인 소변 중화반응으로 동정하였다. 비록 항-Sd^a는 임상적 중요성이 떨어지지만, 고빈도 항원에 대한 항체이기 때문에 교차시험 검사에서 문제가 발생할 수 있다. 항-Sd^a로 추정되는 경우에는 소변으로 중화된 혈청으로 검사하는 것이 부적합 교차시험에 대한 해결책이 될 수 있다.

• Korean Circulation Journal
• /
• 제54권6호
• /
• pp.325-335
• /
• 2024

Background and Objectives: The number of sensitized heart failure patients on waiting lists for heart transplantation (HTx) is increasing. Using the Korean Organ Transplantation Registry (KOTRY), a nationwide multicenter database, we investigated the prevalence and clinical impact of calculated panel-reactive antibody (cPRA) in patients undergoing HTx. Methods: We retrospectively reviewed 813 patients who underwent HTx between 2014 and 2021. Patients were grouped according to peak PRA level as group A: patients with cPRA ≤10% (n= 492); group B: patients with cPRA >10%, <50% (n=160); group C patients with cPRA ≥50% (n=161). Post-HTx outcomes were freedom from antibody-mediated rejection (AMR), acute cellular rejection, coronary allograft vasculopathy, and all-cause mortality. Results: The median follow-up duration was 44 (19-72) months. Female sex, re-transplantation, and pre-HTx renal replacement therapy were independently associated with an increased risk of sensitization (cPRA ≥50%). Group C patients were more likely to have longer hospital stays and to use anti-thymocyte globulin as an induction agent compared to groups A and B. Significantly more patients in group C had positive flow cytometric crossmatch and had a higher incidence of preformed donor-specific antibody (DSA) compared to groups A and B. During follow-up, group C had a significantly higher rate of AMR, but the overall survival rate was comparable to that of groups A and B. In a subgroup analysis of group C, post-transplant survival was comparable despite higher preformed DSA in a desensitized group compared to the non-desensitized group. Conclusions: Patients with cPRA ≥50% had significantly higher incidence of preformed DSA and lower freedom from AMR, but post-HTx survival rates were similar to those with cPRA <50%. Our findings suggest that sensitized patients can attain comparable post-transplant survival to non-sensitized patients when treated with optimal desensitization treatment and therapeutic intervention.